- Corporate Officers - H
- Humphries William D.
Insider Trading History of Humphries William D.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Humphries William D. since 2019.
This trader's CIK number is 1674278.
At the time of last reporting, Humphries William D. was the Officer of Aclaris Therapeutics, Inc.. (stock ticker symbol ACRS).
Also see all insider trading activities at Aclaris Therapeutics, Inc..
Note that in the past
Humphries William D. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Clearside Biomedical, Inc. (CLSD) by Humphries William D.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CLSD | 0 | $0 | 0 | $0 | 22,727 | $9,090 |
| 2022 | CLSD | 0 | $0 | 0 | $0 | 22,727 | $3,409 |
| 2020 | CLSD | 5,586 | $9,943 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Strata Skin Sciences, Inc. (SSKN) by Humphries William D.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | SSKN | 31,733 | $52,777 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Phasebio Pharmaceuticals Inc (PHAS) by Humphries William D.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | PHAS | 0 | $0 | 0 | $0 | 2,538 | $0 |
Yearly summary of insider trading at Aclaris Therapeutics, Inc. (ACRS) by Humphries William D.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | ACRS | 0 | $0 | 0 | $0 | 4,660 | $0 |
| 2023 | ACRS | 0 | $0 | 0 | $0 | 4,507 | $0 |
| 2022 | ACRS | 0 | $0 | 0 | $0 | 3,356 | $0 |
| 2020 | ACRS | 0 | $0 | 0 | $0 | 16,209 | $0 |
Yearly summary of insider trading at Bausch Health Companies Inc. (BHC) by Humphries William D.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | BHC | 0 | $0 | 156,526 | $3,080,529 | 171,770 | $2,169,350 |
| 2019 | BHC | 30,703 | $650,136 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Humphries William D.:
1. Clearside Biomedical, Inc. (CLSD)
2. Strata Skin Sciences, Inc. (SSKN)
3. Phasebio Pharmaceuticals Inc (PHAS)
4. Aclaris Therapeutics, Inc. (ACRS)
5. Bausch Health Companies Inc. (BHC)
Table 1. Insider trading of Clearside Biomedical, Inc. (CLSD) by Humphries William D.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-09-22 | CLSD | Option Ex | 22,727 | .40 | 9,090 |
| 2022-01-10 | CLSD | Option Ex | 22,727 | .15 | 3,409 |
| 2020-08-18 | CLSD | Buy | 5,586 | 1.78 | 9,943 |
Table 2. Insider trading of Strata Skin Sciences, Inc. (SSKN) by Humphries William D.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-03-25 | SSKN | Buy | 16,950 | 1.73 | 29,391 |
| 2022-03-24 | SSKN | Buy | 14,783 | 1.58 | 23,386 |
Table 3. Insider trading of Phasebio Pharmaceuticals Inc (PHAS) by Humphries William D.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-05-19 | PHAS | Option Ex | 2,538 | .00 | 0 |
Table 4. Insider trading of Aclaris Therapeutics, Inc. (ACRS) by Humphries William D.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-01 | ACRS | Option Ex | 4,660 | .00 | 0 |
| 2023-06-02 | ACRS | Option Ex | 4,507 | .00 | 0 |
| 2022-06-03 | ACRS | Option Ex | 3,356 | .00 | 0 |
| 2020-06-06 | ACRS | Option Ex | 7,333 | .00 | 0 |
| 2020-03-02 | ACRS | Option Ex | 8,876 | .00 | 0 |
Table 5. Insider trading of Bausch Health Companies Inc. (BHC) by Humphries William D.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-04 | BHC | Option Ex | 114,055 | 14.38 | 1,640,110 |
| 2020-12-04 | BHC | Sale | 114,055 | 19.87 | 2,266,386 |
| 2020-11-23 | BHC | Option Ex | 1,483 | 14.38 | 21,325 |
| 2020-11-24 | BHC | Option Ex | 21,658 | 14.38 | 311,442 |
| 2020-11-23 | BHC | Sale | 1,483 | 19.63 | 29,115 |
| 2020-11-24 | BHC | Sale | 21,658 | 19.63 | 425,189 |
| 2020-11-27 | BHC | Option Ex | 13,663 | 14.38 | 196,473 |
| 2020-11-27 | BHC | Sale | 13,663 | 19.63 | 268,204 |
| 2020-09-08 | BHC | Sale | 5,667 | 16.17 | 91,635 |
| 2020-02-19 | BHC | Option Ex | 20,911 | .00 | 0 |
| 2019-08-16 | BHC | Buy | 30,703 | 21.18 | 650,136 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Humphries William D.
(Officer of Aclaris Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.